Open original FDA record ↗Recall record
- FDA identifier
- Z-1107-2021
- Company in FDA record
- Phadia US Inc
- FDA classification date
- Feb 11, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Decreased values for EliA ANA Positive Control when using the EliA dsDNA Well lot BFA37/0142 may potentially cause false positive results (increase in patient test results).
Source facts
- Action
- Phadia US Inc. (Initial Importer/Distributor) issued notification to consignees via phone and FedEx overnight delivery Dec. 17-18 . Letter states reason for recall, health risk and action to take: Customers are asked to perform the following steps: 1.Scrap EliA dsDNA Well lot BFA3Y/0142 and order a replacement free of charge 2. Assess test results from EliA dsDNA Well lot BFA3Y/0142 and determine if retesting of samples is warranted in accordance with internal operating procedures. 3. Complete the Acknowledgement Form in the Medical Device Field Safety Notice and return the response to the contact person described. Any questions concerning this issue, contact Phadia US Technical Support at 1-800-346-4364, option #2.
- Initiated
- 2020-12-14
- Root cause
- Under Investigation by firm
- Terminated
- 2022-08-04
- Distribution
- US Nationwide distribution.
- Recall number
- Z-1107-2021
- Recall status
- Terminated
- CDRH record ID
- 185460
- FDA classified
- 2021-02-11
- Recall event number
- 87161